+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
07.03.2023 23:30:00

Oakworth Capital Bank Finances Facility Supporting Navis Clinical Laboratories' Purchase of Lab Business

BIRMINGHAM, Ala., March 7, 2023 /PRNewswire/ -- Oakworth Capital Bank (OTCQX: OAKC) acted as servicer and sole agent for a senior secured credit facility that supports the Navis Clinical Laboratories purchase of the clinical laboratory business of Cordant Health Solutions. Proceeds from the financing were used to fund the acquisition, as well support Navis' ongoing working capital needs.

Oakworth Capital Bank Logo (PRNewsfoto/Oakworth Capital Bank)

Oakworth Commercial Banking Advisor Terrell Taylor organized the team on behalf of the bank. Taylor's long-tenured experience in serving the healthcare industry played a key role in providing Navis with a seamless, easy experience, based on expert advice.

"This transaction displays Oakworth's unique ability to leverage our healthcare expertise and streamlined diligence and credit process to help provide debt capital to companies like Navis," said Taylor. "We are pleased to invest in such a strong and experienced management team that possesses a great reputation and track record of success in the lab space."

Navis President and CEO Richard Stripp, Ph. D. added, "At the onset, Oakworth assured us of their ability to move quickly and showed real flexibility during negotiations and closing. We appreciate the efficient and transparent way in which Oakworth worked with us. We are fortunate to have them as a key advisor and banking partner as we build our lab company."

Navis, headquartered in Franklin, Tenn., provides innovative solutions tailored for healthcare providers who treat patients with substance use disorder, chronic pain, mental health conditions and other chronic health conditions. Its proprietary, patented medication-monitoring tool, CORE (Comprehensive Oral Fluid Rx Evaluation), uses saliva samples to help providers determine if medication is present at a steady-state level consistent with the prescribed dosing regimen or if there are metabolic or health issues that need more investigation. The company currently has three laboratories located in New York, Massachusetts and Washington and serves clients throughout the United States.

About Oakworth Capital Bank
Oakworth Capital, Inc. operates as the bank holding company for Oakworth Capital Bank (OTCQX: OAKC). Oakworth was founded in 2008 and operates three offices in the Southeast, including its headquarters in Birmingham, Alabama and plans to open a fourth office in 2023. Oakworth provides commercial and private banking, wealth management and advisory services to clients across the United States.

Oakworth has been named the #1 "Best Bank to Work for" for the past five years in a row (2018-2022) by American Banker. Additionally, Oakworth has earned a Net Promoter Score (NPS) of 96 out of 100 (January 2022 to January 2023) and has a client retention rate of 95% in 2022. As of Dec. 31, 2022, Oakworth had $1.3 billion in total assets, $974 million in gross loans, $1.2 billion in deposits and $1.8 billion in wealth and trust assets under management. For more information, visit www.oakworth.com.

About Navis Clinical Laboratories
Navis Clinical Laboratories (navisclinical.com) is committed to providing cutting-edge toxicological, molecular and clinical laboratory testing solutions for healthcare providers in the behavioral health, mental health, chronic pain management and addiction treatment spaces, as well as for hospitals and health systems, to increase patient access to whole-person healthcare and improve overall health and well-being.

For more information contact: 
Sonia Blumstein
Phone:  205.271.2017 
Email: Sonia.Blumstein@oakworth.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oakworth-capital-bank-finances-facility-supporting-navis-clinical-laboratories-purchase-of-lab-business-301765136.html

SOURCE Oakworth Capital Bank

Nachrichten zu Oakworth Capital Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Oakworth Capital Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Oakworth Capital Inc Registered Shs 30,80 0,82% Oakworth Capital Inc Registered Shs